These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Polymorphisms of the KCNQ1 gene are associated with the therapeutic responses of sulfonylureas in Chinese patients with type 2 diabetes. Li Q, Tang TT, Jiang F, Zhang R, Chen M, Yin J, Bao YQ, Cheng X, Hu C, Jia WP. Acta Pharmacol Sin; 2017 Jan; 38(1):80-89. PubMed ID: 27694910 [Abstract] [Full Text] [Related]
4. IGF2BP2 variations influence repaglinide response and risk of type 2 diabetes in Chinese population. Huang Q, Yin JY, Dai XP, Pei Q, Dong M, Zhou ZG, Huang X, Yu M, Zhou HH, Liu ZQ. Acta Pharmacol Sin; 2010 Jun; 31(6):709-17. PubMed ID: 20523342 [Abstract] [Full Text] [Related]
8. A variation in KCNQ1 gene is associated with repaglinide efficacy on insulin resistance in Chinese Type 2 Diabetes Mellitus Patients. Zhou X, Zhu J, Bao Z, Shang Z, Wang T, Song J, Sun J, Li W, Adelusi TI, Wang Y, Lv D, Lu Q, Yin X. Sci Rep; 2016 Nov 18; 6():37293. PubMed ID: 27857189 [Abstract] [Full Text] [Related]
10. Association analysis of SLC30A8 rs13266634 and rs16889462 polymorphisms with type 2 diabetes mellitus and repaglinide response in Chinese patients. Huang Q, Yin JY, Dai XP, Wu J, Chen X, Deng CS, Yu M, Gong ZC, Zhou HH, Liu ZQ. Eur J Clin Pharmacol; 2010 Dec 18; 66(12):1207-15. PubMed ID: 20809084 [Abstract] [Full Text] [Related]
14. PPARD rs2016520 polymorphism affects repaglinide response in Chinese Han patients with type 2 diabetes mellitus. Song JF, Wang T, Zhu J, Zhou XY, Lu Q, Guo H, Zhang F, Wang Y, Li W, Wang DD, Cui YW, Lv DM, Yin XX. Clin Exp Pharmacol Physiol; 2015 Jan 18; 42(1):27-32. PubMed ID: 25311380 [Abstract] [Full Text] [Related]
15. A variant of GRK5 is associated with the therapeutic efficacy of repaglinide in Chinese Han patients with type 2 diabetes mellitus. Shang Z, Han F, Zhou X, Bao Z, Zhu J, Wang T, Lu Q, Du L, Li W, Lv D, Yin X. Drug Dev Res; 2018 May 18; 79(3):129-135. PubMed ID: 29663513 [Abstract] [Full Text] [Related]
16. Association study of four variants in KCNQ1 with type 2 diabetes mellitus and premature coronary artery disease in a Chinese population. Chen Z, Zhang X, Ma G, Qian Q, Yao Y. Mol Biol Rep; 2010 Jan 18; 37(1):207-12. PubMed ID: 19575309 [Abstract] [Full Text] [Related]
18. Identifying the association between single nucleotide polymorphisms in KCNQ1, ARAP1, and KCNJ11 and type 2 diabetes mellitus in a Chinese population. Li Y, Shen K, Li C, Yang Y, Yang M, Tao W, He S, Shi L, Yao Y. Int J Med Sci; 2020 Jan 18; 17(15):2379-2386. PubMed ID: 32922204 [Abstract] [Full Text] [Related]
19. KCNQ1 haplotypes associate with type 2 diabetes in Malaysian Chinese Subjects. Saif-Ali R, Ismail IS, Al-Hamodi Z, Al-Mekhlafi HM, Siang LC, Alabsi AM, Muniandy S. Int J Mol Sci; 2011 Jan 18; 12(9):5705-18. PubMed ID: 22016621 [Abstract] [Full Text] [Related]
20. Effect of genetic polymorphism of UCP2-866 G/A on repaglinide response in Chinese patients with type 2 diabetes. Wang S, Se YM, Liu ZQ, Lei MX, Hao-BoYang, Sun ZX, Nie SD, Zeng XM, Wu J. Pharmazie; 2012 Jan 18; 67(1):74-9. PubMed ID: 22393835 [Abstract] [Full Text] [Related] Page: [Next] [New Search]